General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions


Endoscopy procedures and biopsy are commonly used in the diagnosis of Crohn’s disease as well as medical imaging and description of the disease and symptoms. There are no medications or surgery that can cure Crohn’s disease. The treatment directs to minimize the effect of symptoms, maintain remission and prevent deterioration in the patient’s condition.
Treatment options include medication to control the symptoms, lifestyle and dietary changes, reduction of stress, moderate activity and exercise. Acute treatment involves antibiotics, anti-inflammatory drugs and corticosteroids. Prolonged use of corticosteroids has significant side-effects; as a result, they are, in general, not used for long-term treatment. Most of these therapies (aminosalicylates, steroids and immunomodulators) provide symptomatic improvement but fail to change the disease course.
Aminosalicylates are often more effective in ulcerative colitis. This treatment showed positive results in mild to moderate UC. Aminosalicylates may be helpful to control mild inflammation and symptoms of CD. Monotherapy is an option to induce remission in people with a first presentation or a single inflammatory exacerbation of CD. It is usually offered with a conventional glucocorticosteroid (prednisolone, methylprednisolone or intravenous hydrocortisone).